Avecho Biotechnology Ltd has released a press release.
Appendix 4E and Annual Report 31 December 2023
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- December 2023 Quarterly Activities Report & Appendix 4C
- September 2023 Quarterly Activities Report & Appendix 4C
- Reinstatement to Official Quotation
- Avecho raises further $6M for Phase III trial
- Voluntary Suspension
Later from Avecho Biotechnology
- AVE receives final ethics approval for Phase III CBD trial
- Avecho meets TGA ahead of Phase III Clinical Trial
- Avecho commences Phase III insomnia trial
- March 2024 Quarterly Activities Report & Appendix 4C
- First Patient dosed in Phase III insomnia trial
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology